|
× |
 |
Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics PDF |
$40.00 |
|
$40.00 |
|
× |
|
Posttraumatic Stress Disorder Exacerbation as a Result of Public Masking in Times of COVID-19 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antidepressant Medication Change in a Clinical Treatment Setting: A Comparison of the Effectiveness of Selective Serotonin Reuptake Inhibitors PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
Obsessive-Compulsive Symptoms During Treatment With Olanzapine and Risperidone: A Prospective Study of 113 Patients With Recent-Onset Schizophrenia or Related Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Outcome of Patients With Major Depressive Disorder After Serious Suicide Attempt PDF |
$40.00 |
|
$40.00 |
|
|
